Table 1.

Prevalence of Plasmodium falciparum based on LM and PfHRP-2/pLDH RDT screening in Mawza District, Taiz Governorate, Yemen

		LM		PfHRP-2/pLDH RDT
	No	n	% (95 % CI)	n	% (95 % CI)
Overall	488	52	10.7 (8.2–13.7)	160	32.8 (28.8–37.1)
Age (years)
≥10	424	46	10.8 (8.2–14.2)	136	32.1 (27.8–36.7)
<10	64	6	9.4 (4.4–19.0)	24	37.5 (26.7–49.8)
Fever 48 h prior to screening
Yes	51	45	88.2 (76.6–94.5)	48	94.1 (84.1–98.0)
No	437	7	1.6 (1.0–3.3)	112	25.6 (21.8–29.9)
History of anti-malarial drug intake 1 week prior to the survey
Yes	157	20	13.0 (9.0–19.0)	76	48.0 (41.0–56.0)
No	331	32	10.0 (7.0–13.0)	84	25.0 (21.0–30.0)

n number positive, CI confidence interval LM light microscopy PfHRP-2 P. falciparum histidine-rich protein-2, pLDH Plasmodium lactate dehydrogenase, RDT rapid diagnostic test